Insiders Lexicon Pharmaceuticals, Inc.

Equities

LXRX

US5288723027

Market Closed - Nasdaq Other stock markets 01:30:00 09/05/2024 am IST			5-day change	1st Jan Change
1.77 ^USD	0.00%		+7.27%	+15.69%

02/05	Transcript : Lexicon Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 02, 2024
02/05	Earnings Flash (LXRX) LEXICON PHARMACEUTICALS Posts Q1 Revenue $1.1M, vs. Street Est of $1.4M	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lexicon Pharmaceuticals' Chief Executive Lonnel Coats to Retire	29/04	MT
Lexicon Pharmaceuticals, Inc. Announces Resignation of Lonnel Coats as Member of Its Board of Directors, Effective July 7, 2024	29/04	CI
Lexicon Pharmaceuticals, Inc. Announces Resignation of Lonnel Coats as Chief Executive Officer, Effective from July 7, 2024	29/04	CI
Lexicon Pharmaceuticals, Inc. Appoints Lisa DeFrancesco as Head of Investor Relations and Corporate Strategy, Effective November 13, 2023	01/23/01	CI
Lexicon Pharmaceuticals Insider Bought Shares Worth $1,103,957, According to a Recent SEC Filing	13/23/13	MT
Lexicon Pharmaceuticals, Inc. Announces the Retirement of Alan S. Nies from Board of Directors, Effective October 26, 2023	12/23/12	CI
Lexicon Pharmaceuticals Hires Tom Garner as Chief Commercial Officer	09/23/09	MT
Lexicon Pharmaceuticals, Inc. Appoints Tom Garner as Senior Vice President and Chief Commercial Officer	09/23/09	CI
Lexicon Pharmaceuticals, Inc. Elects Diane E. Sullivan to Its Board of Directors	28/23/28	CI
Lexicon Pharmaceuticals, Inc. Announces Resignation of Frank P. Palantoni from Board of Directors, Effective July 27, 2023	25/23/25	CI
Insider Buy: Lexicon Pharmaceuticals	02/22/02	MT
Lexicon Pharmaceuticals, Inc. Appoints Jeffrey L. Wade as President, Effective October 1, 2021	10/21/10	CI
Craig Granowitz Joins Lexicon Pharmaceuticals, Inc as Senior Vice President and Chief Medical Officer, Effective August 2, 2021	30/21/30	CI
Lexicon Pharmaceuticals, Inc. Announces Resignation of Praveen Tyle as Executive Vice President, Research and Development, Effective as of April 26, 2021	02/21/02	CI
Insider Trends: Insider Purchase Continues Lexicon Pharmaceuticals Positive Trend	18/20/18	MT
Insider Trends: Lexicon Pharmaceuticals Sees 90 Days of Insider Selling, Trend Scaled Back with Share Buy	18/20/18	MT
Lexicon Pharmaceuticals, Inc. Announces Management Changes, Effective September 30, 2020	04/20/04	CI
Lexicon Pharmaceuticals, Inc. Announces Executive Appointments	21/16/21	CI
Lexicon Pharmaceuticals, Inc. Appoints Praveen Tyle as Executive Vice President of Research and Development, Effective May 16, 2016	10/16/10	CI
Lexicon Pharmaceuticals, Inc. Announces Resignation of Brian P. Zambrowicz as Executive Vice President and Chief Scientific Officer	24/15/24	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Lexicon Pharmaceuticals, Inc.

Equities

LXRX

US5288723027

Insiders

Filters